Stock Rich List
#10125 on the rich list of 14,644 insiders

Michelle L. Basil

EVP and General Counsel at Haemonetics. Based in Boston, Massachusetts.

$8.3M
in disclosed stock, −$171K (−2.03%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
Rank
10125th of 14,644
Companies held
1
Largest holding
HAE, 100.0% of total
Latest SEC filing
May 15, 2026

What the $8.3M is made of

Holdings counted

All filings on SEC.gov
CompanyHow heldSharesPriceValueShare of totalReported
Haemonetics HAE
Common Stock
Directly68,829$120.37$8.3M100.0%Form 4, May 15, 2026

Share counts are the amounts Michelle L. Basil reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.

Nearby on the list

Full list
Nearby ranks
RankNameStock holdingsToday
10122Michael Amend
Chief Enterprise Tech. Officer, Ford Motor. Dearborn, MI
$8.3M−$29K (−0.35%)
10123Michael Stuart Klein
Director, Claritev. New York, NY
$8.3M−$918K (−9.97%)
10124Ann M. Dennison
Executive Vice President, Nasdaq. Bloomfield, CT
$8.3M−$201K (−2.36%)
10125Michelle L. Basil
EVP and General Counsel, Haemonetics. Boston, MA
$8.3M−$171K (−2.03%)
10126Kristina M. Johnson
Director, Cisco Systems. San Jose, CA
$8.3M−$180K (−2.13%)
10127Michael D. Dale
SENIOR VICE PRESIDENT, Abbott Laboratories. Minneapolis, MN
$8.3M−$68K (−0.81%)
10128Mark McHugh
President and CEO, Rayonier. Wildlight, FL
$8.3M−$235K (−2.76%)

Other Haemonetics insiders

All HAE insiders

Questions

How much stock does Michelle L. Basil own?

Michelle L. Basil holds $8,284,947 in listed stock based on SEC filings and current prices, mostly Haemonetics (HAE). That ranks 10125th on the Stock Rich List.

Is this Michelle L. Basil's net worth?

No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.